Oculus Prices Low

Oculus Innovative Sciences Inc., a Petaluma, Calif.-based developer of products intended to help prevent and treat infections in chronic and acute wounds, priced 3.025 million common shares at $8 per share, for an IPO take of approximately $24.2 million. It had planned to sell 3.5 million common shares at between $8 and $10 per share. It will trade on the Nasdaq under ticker symbol OCLS, while Roth Capital Partners served as lead underwriter. Oculus had raised over $56 million in private equity funding, from firms like Western Technology Investment and Brookstreet Securities. www.oculusis.com